Search

Search Constraints

You searched for: Author/Creator Dhermain, Frederic

Search Results

1. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. Issue 6 (June 2021)

2. An Unusual Case of Constitutional Mismatch Repair Deficiency Syndrome With Anaplastic Ganglioglioma, Colonic Adenocarcinoma, Osteosarcoma, Acute Myeloid Leukemia, and Signs of Neurofibromatosis Type 1: Case Report. Issue 1 (July 2015)

3. An Unusual Case of Constitutional Mismatch Repair Deficiency Syndrome With Anaplastic Ganglioglioma, Colonic Adenocarcinoma, Osteosarcoma, Acute Myeloid Leukemia, and Signs of Neurofibromatosis Type 1: Case Report. Issue 1 (4th April 2015)

4. Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression. Issue 5 (18th December 2013)

5. Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group. Issue 6 (4th February 2021)

6. CTIM-01. GLIOBLASTOMA RE-IRRADIATION: IMPACT OF CONCOMITANT CHEMOTHERAPY. (9th November 2020)

7. Evidence-based management of adult patients with diffuse glioma – Authors' reply. Issue 8 (August 2017)

8. Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials. (March 2022)

9. High‐dose busulfan–thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma. Issue 5 (28th January 2014)

10. Intellectual, educational, and situation-based social outcome in adult survivors of childhood medulloblastoma. (2nd January 2019)